Akros SCHK HK-Global Genomics Index

The index pairs a Hong Kong sleeve of Stock Connect Southbound-eligible stocks with a global sleeve of developed-market stocks excluding Hong Kong and China, at a fixed 62%/38% split. From pharmaceutical, life-science research, medical-device, and diagnostics industries, Akros's NEXUS engine selects up to 30 Hong Kong and 20 global names by genomics relevance, filling any shortfall by market capitalization. Constituents are weighted by an equal blend of thematic score and free-float market capitalization, subject to an 8% cap in the Hong Kong sleeve and 5% in the global sleeve. The index is rebalanced semi-annually.